Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation

November 19, 2023 updated by: Paulina Kurleto, Andrzej Frycz Modrzewski Krakow University

In Poland, approximately 4.2 million people suffer from chronic kidney disease [1]. In December 2022, a total of 20,198 patients were dialyzed in the country, of which 96% by hemodialysis (HD) and 4% by peritoneal dialysis (DO). In 2022, kidney transplantation was performed in 2.6% of patients dialyzed using the HD method and in 15.4% of patients dialyzed using the DO method [2]. According to the data of the Organizational and Coordination Center for Transplantation "Poltransplant", in 2022 on the national waiting list 1,119 people were registered for kidney transplantation. The average age of those waiting was 49 years [3]. In Poland, according to data from 2022, the average waiting time for transplantation in the case of the first transplant from the moment of registration on the waiting list was 387 days, and 1,106 days from the start of dialysis. Data show that only 5.5% of patients undergoing renal replacement therapy are on the waiting list [3].

Therefore, a study was designed to examine the knowledge and attitudes towards kidney transplantation among dialysis patients. The study will include a representative group of dialysis patients from all voivodeships and aims to identify positive and negative aspects related to patients' attitudes towards kidney transplantation.

The scientific value of the study is worth emphasizing, because so far in Poland no research has been conducted on the knowledge and attitudes towards kidney transplantation among dialysis patients in all voivodeships in the country. The study will identify the level of knowledge and attitudes of dialysis patients towards transplantation. The results of this study may contribute to the development and implementation of new educational and information programs that may increase the level of knowledge and influence attitudes towards transplantation, which may largely contribute to the increase in transplantation among people with chronic kidney disease.

References:

  1. Gellert R, Durlik M, Małgorzewicz S. Raport 2019. Ogólnopolskie Badanie Pacjentów Nefrologicznych. Forum Nefrologiczne. 2020;13(3):149-63.
  2. Dębska-Ślizień A, Rutkowski B, Rutkowski P et al. (2022). Aktualny stan leczenia nerkozastępczego w Polsce-2022. Nefrol Dializoter Pol, 26: 21-38.
  3. Centrum Organizacyjno- Koordynacyjne do spraw transplantacji-Poltransplant. Biuletyn Informacyjny 2023. https://files.poltransplant.org.pl/Biuletyn_2023_www.pdf Accessed 13 November 2023.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Malopolska
      • Krakow, Malopolska, Poland, 30-705
        • Recruiting
        • Andrzej Frycz Modrzewski Krakow University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

People undergoing dialysis in all voivodeships in Poland

.

Description

Inclusion Criteria:

(1) patients on dialysis for at least 3 months; (2) patients who have no medical contraindications to kidney transplantation and patients who are temporarily suspended from KLO; (3) voluntary consent to participate in the study; (4) communicative knowledge of Polish

Exclusion Criteria:

(1) inability to make an informed and independent decision; (2) patients with absolute medical contraindications to kidney transplantation, i.e. recently diagnosed or disseminated cancer, persistent untreated infection, severe irreversible systemic disease, expected short life span, lack of cooperation (alcohol and drug addiction, mental illness)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation
Time Frame: 16 months
Attitudes and Knowledge will be measured using a 51-item self-report questionnaire with single and multi-choice questions.
16 months
Intensity of pain and attitudes towards kidney transplantation.
Time Frame: 16 months

To investigate the relationship between the intensity of pain in dialysis patients and their attitudes towards kidney transplantation.

Standardized tool will be the Numeric Rating Scale (NRS). Pain intensity will be assessed using the NRS, where 0 meant no pain and 10 maximum pain. Numeric scores of 1-3, 4-6, and 7-10 corresponded to mild, moderate and severe pain

16 months
Anxiety and Depression
Time Frame: 16 months

To investigate the relationship between the level of anxiety and depression of dialysis patients and their attitudes towards kidney transplantation.

Emotional state will be evaluated using HADS [21, 22], which was validated for Polish conditions. It consists of 7 items grouped in sub-scales: anxiety and depression. The answers describe the patient's well-being over the last week and are coded on a scale of 0-3 points. The total score amounts to 0-21 points (0-7 points = norm, 8-10 = borderline, ≥11 points = clinical levels of symptoms).

16 months
Acceptance of the disease
Time Frame: 16 months
To measure it, the Acceptance of Illness Scale (AIS), by Felton, Revenson and Hinrichsen, in the Polish adaptation by Juczyński was used [4]. It consists of 8 questions describing the consequences of poor health. The questions concerned the limitations imposed by the disease, lack of self-sufficiency, feeling of dependence on others and reduced self-esteem. Questions contained a five-point scale, and the person described their current health condition by marking the number: 1 - I strongly agree, 2 - I agree, 3 - I don't know, 4 - I disagree, 5 - I strongly disagree. Strong consent meant poor adaptation to the disease, while lack of consent meant acceptance of the disease. The degree of acceptance of the current health condition was the sum of all points, ranging from 8 to 40 points. Three point ranges were created to determine the degree of acceptance, where the number of points: 8-18 meant lack of acceptance of the disease, 19-29 - average acceptance, 30-40 - good acceptance.
16 months
Patient Request Form
Time Frame: 16 months
To investigate the relationship between patient expectations and their attitudes towards kidney transplantation. Patient expectations will be measured using the Patient Request Form - the scale consists of 18 statements regarding expectations towards the doctor/medical staff related to explaining the disease, seeking support and obtaining information about tests and treatment. The theoretical range of the scale is from 0 to 12 points. The higher the score, the greater the patient's expectations for specific help.
16 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Paulina Kurleto, PhD, Andrzej Frycz Modrzewski Krakow University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Estimated)

August 31, 2024

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

November 19, 2023

First Submitted That Met QC Criteria

November 19, 2023

First Posted (Actual)

November 28, 2023

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 19, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • KAAFMWLNZ/34/0/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Transplant

Subscribe